The HOST-EXAM is the first large-scale randomized trial comparing clopidogrel with aspirin as chronic maintenance antithrombotic monotherapy after 6 to 18 ...

17 апр. 2023 г. · The HOST-EXAM trial showed that clopidogrel monotherapy is superior to aspirin monotherapy as chronic maintenance therapy among patients.

7 нояб. 2022 г. · The HOST-EXAM Extended study supports clopidogrel as the preferable antiplatelet agent prescribed for secondary prevention of coronary artery disease.

16 мая 2021 г. · The HOST-EXAM is the first randomised trial to compare clopidogrel and aspirin monotherapy in patients who received percutaneous coronary ... Не найдено: journal club

The HOST-EXAM trial 1 was a prospective, randomised, open-label trial investigating clopidogrel monotherapy versus aspirin therapy in patients undergoing PCI ...

12 сент. 2022 г. · The aim of this study was to compare the effect of clopidogrel vs aspirin monotherapy in relation to the clinical presentation of ACS among patients stabilized ... Не найдено: club | Нужно включить: club

12 сент. 2021 г. · Aspirin versus Clopidogrel for chronic maintenance mono therapy after Percutaneous Coronary Intervention (HOST-EXAM): an ...

The HOST-EXAM Extended study reported the benefit of clopidogrel monotherapy over aspirin monotherapy in secondary prevention after percutaneous coronary ...

22 сент. 2023 г. · The HOST-EXAM Extended study reported the benefit of clopidogrel monotherapy over aspirin monotherapy in secondary prevention after percutaneous coronary ...

9 окт. 2023 г. · HOST-EXAM Analysis: Clopidogrel Shows Benefit vs. Aspirin After Post-PCI DAPT, Regardless of Patients' Ischemic, Bleeding Risks. Posted: 10/09/ ...